Stoke Therapeutics

Filed a patent for "opa1 antisense oligomers for treatment of conditions and diseases" on Thu, February 20, 2025

Filed a patent for "methods for treating conditions and diseases" on Mon, July 24, 2023

Filed a patent for "methods for treating conditions and diseases" on Fri, March 22, 2024

Filed a patent for "antisense oligomer formulations" on Tue, February 14, 2023

Filed a patent for "compounds and methods for treating human subjects" on Wed, April 26, 2023

Filed a patent for "compounds and methods for treating human subjects" on Wed, May 3, 2023

Filed a patent for "opa1 antisense oligomers for treatment of conditions and diseases" on Wed, May 31, 2023

Filed a patent for "antisense oligomer formulations" on Thu, January 25, 2024

Filed a patent for "antisense oligomers for treatment of non-sense mediated rna decay based conditions and diseases" on Thu, August 1, 2024

Filed a patent for "compounds for treatment of conditions and diseases" on Fri, July 29, 2022

Filed a patent for "antisense oligomers for treatment of non-sense mediated rna decay based conditions and diseases" on Mon, October 31, 2022

Filed a patent for "opa1 antisense oligomers for treatment of conditions and diseases" on Thu, September 14, 2023

Filed a patent for "antisense oligomers for treatment of non-sense mediated rna decay based conditions and diseases" on Thu, February 1, 2024

Filed a patent for "opa1 antisense oligomers for treatment of conditions and diseases" on Thu, August 10, 2023

Filed a patent for "compositions for treatment of conditions and diseases associated with polycystin expression" on Thu, April 11, 2024

Filed a patent for "opa1 antisense oligomers for treatment of conditions and diseases" on Thu, March 28, 2024

Filed a patent for "antisense oligomers for treatment of conditions and diseases" on Thu, May 9, 2024

Filed a patent for "antisense oligomers for treatment of non-sense mediated rna decay based conditions and diseases" on Wed, June 1, 2022